-transparent.png){kind=logo}
Biosimilar G-CSF (filgrastim) is effective for peripheral blood stem cell mobilization and non-cryopreserved autologous transplantation. 2013
Hematology and Cell Therapy Department, Establishment Hospital University 1st November, Oran, Algeria. Electronic address: yafour.nabil@yahoo.fr.
Related Publications
N Yafour, and
M Brahimi, and
S Osmani, and
A Arabi, and
R Bouhass, and
M A Bekadja
January 2014,
Theranostics,
N Yafour, and
M Brahimi, and
S Osmani, and
A Arabi, and
R Bouhass, and
M A Bekadja
January 2016,
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
N Yafour, and
M Brahimi, and
S Osmani, and
A Arabi, and
R Bouhass, and
M A Bekadja
April 2014,
Advances in therapy,
N Yafour, and
M Brahimi, and
S Osmani, and
A Arabi, and
R Bouhass, and
M A Bekadja
June 2024,
Transfusion,
N Yafour, and
M Brahimi, and
S Osmani, and
A Arabi, and
R Bouhass, and
M A Bekadja
August 2016,
Vox sanguinis,
N Yafour, and
M Brahimi, and
S Osmani, and
A Arabi, and
R Bouhass, and
M A Bekadja
November 2015,
Transfusion,
N Yafour, and
M Brahimi, and
S Osmani, and
A Arabi, and
R Bouhass, and
M A Bekadja
January 2016,
Current medicinal chemistry,
N Yafour, and
M Brahimi, and
S Osmani, and
A Arabi, and
R Bouhass, and
M A Bekadja
November 1994,
[Hokkaido igaku zasshi] The Hokkaido journal of medical science,
N Yafour, and
M Brahimi, and
S Osmani, and
A Arabi, and
R Bouhass, and
M A Bekadja
December 1999,
Asian Pacific journal of allergy and immunology,
N Yafour, and
M Brahimi, and
S Osmani, and
A Arabi, and
R Bouhass, and
M A Bekadja
January 1993,
Lancet (London, England),
